Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial
Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page
- Check5 days agoChange DetectedNo textual changes were reported for the page; the content remains the same as the previous version.SummaryDifference0.1%

- Check12 days agoChange DetectedA new revision tag shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a software/deployment update and does not alter visible content.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page revision updated from v3.6.0 to v3.6.2, signaling a minor update to the page's backend/metadata. It does not indicate changes to the study content displayed.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now indicates recruitment is closed and introduces new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an Intervention/Treatment area, and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check41 days agoChange DetectedRevision: v3.5.5 was added to the page, updating the displayed version. The previous Revision: v3.5.4 label was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedNo additions or deletions were provided for this page, so the page content remains unchanged.SummaryDifference0.1%

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.